“Parkinson’s Disease Treatment and the Role of Genetic Polymorphisms in the Efficacy and Adverse Effects ”, Precis. Med. Com., vol. 1, no. 1, pp. 25–47, Dec. 2021, doi: 10.55627/pmc.001.01.0104.